Kalafatis M, Takahashi Y, Girma J P, Meyer D
National de la Sante et de la Recherche Medicale U. 143, Hôpital de Bicêtre, Paris, France.
Blood. 1987 Nov;70(5):1577-83.
A collagen-binding domain of von Willebrand factor (vWF) has been identified in the central part of the molecule by comparing the binding properties of vWF and Staphylococcus aureus V-8 protease-generated vWF fragments with collagen. The binding of purified human vWF to human type III collagen was found to be specific. At saturation, 38 to 50.2 micrograms of vWF bound per milligram of collagen. Scatchard plots derived from binding isotherms demonstrated the presence of at least two classes of binding sites. Purified vWF was digested with S aureus V-8 protease into two complementary fragments (SpIII and SpII). SpII, the C-terminal end of vWF (amino acid residues 1,366 to 2,050), was totally devoid of affinity for collagen. Contrarily, purified SpIII, the N-terminal part of vWF (residues 1 to 1,365), totally displaced vWF binding and specifically bound to collagen. At saturation, 25 to 45 micrograms of SpIII bound per milligram of collagen. Scatchard plots demonstrated the presence of a single class of binding sites. SpIII was further digested with the same enzyme to generate SpI, a 52-kilodalton fragment from the C-terminal part of SpIII (residues 911 to 1,365). Spl induced a dose-dependent inhibition of both vWF and SpIII binding to collagen. A series of six monoclonal antibodies against SpIII that completely abolished vWF and SpIII interaction with collagen also bound to SpI. In conclusion, SpI extending between amino acid residues 911 and 1,365 of vWF contains a specific site that interacts with human type III collagen.
通过比较血管性血友病因子(vWF)和金黄色葡萄球菌V-8蛋白酶产生的vWF片段与胶原蛋白的结合特性,在该分子的中心部分鉴定出了vWF的一个胶原蛋白结合结构域。发现纯化的人vWF与人III型胶原蛋白的结合具有特异性。在饱和状态下,每毫克胶原蛋白结合38至50.2微克vWF。从结合等温线得出的Scatchard图表明至少存在两类结合位点。用金黄色葡萄球菌V-8蛋白酶将纯化的vWF消化成两个互补片段(SpIII和SpII)。SpII是vWF的C末端(氨基酸残基1366至2050),对胶原蛋白完全没有亲和力。相反,纯化的SpIII是vWF的N末端部分(残基1至1365),完全取代了vWF的结合并特异性结合胶原蛋白。在饱和状态下,每毫克胶原蛋白结合25至45微克SpIII。Scatchard图表明存在单一类别的结合位点。用同一种酶进一步消化SpIII以产生SpI,这是一个来自SpIII C末端部分(残基911至1365)的52千道尔顿片段。SpI诱导vWF和SpIII与胶原蛋白结合的剂量依赖性抑制。一系列六种针对SpIII的单克隆抗体完全消除了vWF和SpIII与胶原蛋白的相互作用,它们也与SpI结合。总之,vWF中氨基酸残基911至1365之间的SpI包含一个与人类III型胶原蛋白相互作用的特定位点。